Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methylprednisolone hemisuccinate
Drug ID BADD_D01435
Description A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.
Indications and Usage Adjunctive therapy for short-term administration in rheumatoid arthritis.
Marketing Status Prescription; Discontinued
ATC Code D07AA01; D10AA02; H02AB04
DrugBank ID DB14644
KEGG ID D05000
MeSH ID D008776
PubChem ID 16923
TTD Drug ID Not Available
NDC Product Code 57582-012; 24002-0015; 82298-109; 22552-0024; 52128-152
Synonyms Methylprednisolone Hemisuccinate | Hemisuccinate, Methylprednisolone | Methylprednisolone Succinate | Succinate, Methylprednisolone | Urbason-Soluble | UrbasonSoluble | Solu-Medrol | Solumedrol | A-MethaPred | Methylprednisolone Sodium Succinate | Sodium Succinate, Methylprednisolone | Methylprednisolone Hemisuccinate Monosodium Salt | 6 alpha-Methylprednisolone Sodium Hemisuccinate | Methylprednisolone Sodium Hemisuccinate | Sodium Hemisuccinate, Methylprednisolone
Chemical Information
Molecular Formula C26H34O8
CAS Registry Number 2921-57-5
SMILES CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.0020.111913%
Abdominal pain upper07.01.05.003--
Abscess11.01.08.001--Not Available
Acne23.02.01.0010.013989%Not Available
Acute respiratory distress syndrome22.01.03.0010.014597%
Adrenal insufficiency14.11.01.004; 05.01.02.0010.027978%
Affective disorder19.04.04.001--Not Available
Ageusia17.02.07.001; 07.14.03.0030.020984%Not Available
Aggression19.05.01.0010.048962%Not Available
Agitation19.06.02.001; 17.02.05.0120.139891%
Agranulocytosis01.02.03.0010.034973%Not Available
Alanine aminotransferase increased13.03.01.0030.055957%
Alkalosis hypokalaemic14.01.02.002--Not Available
Altered state of consciousness19.07.01.003; 17.02.04.0010.027978%Not Available
Alveolitis allergic22.01.01.002; 10.01.03.0080.013989%Not Available
Amnesia19.20.01.001; 17.03.02.0010.027978%
Anaemia01.03.02.001--
Anaphylactic reaction24.06.03.006; 10.01.07.0010.272788%
Anaphylactic shock24.06.02.004; 10.01.07.0020.244810%Not Available
Anger19.04.02.0010.020984%Not Available
Angioedema23.04.01.001; 10.01.05.0090.048962%Not Available
Anxiety19.06.02.0020.125902%
Arachnoiditis17.06.01.001; 12.02.04.002--
Arrhythmia02.03.02.001--Not Available
Arthralgia15.01.02.001--
Aspartate aminotransferase increased13.03.01.0060.034973%
Asthenia08.01.01.001--Not Available
Asthma10.01.03.010; 22.03.01.0020.020984%Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 17 Pages